Versant Venture Management, LLC — 13F holdings

Versant Venture Management, LLC reported 8 holdings worth $163M in its 13F filing for Q2 2026, filed August 12, 2026.

Largest positions

1. GLUE MONTE ROSA THERAPEUTICS INC — $77.0M (47.3%)
2. IPSC CENTURY THERAPEUTICS INC — $29.8M (18.3%)
3. JBIO JADE BIOSCIENCES INC — $22.0M (13.6%)
4. LENZ LENZ THERAPEUTICS INC — $15.1M (9.3%)
5. CTNM CONTINEUM THERAPEUTICS INC — $8.89M (5.5%)
6. CRSP CRISPR Therapeutics AG — $8.12M (5.0%)
7. SKYE SKYE BIOSCIENCE INC — $1.39M (0.9%)
8. TEMPEST THERAPEUTICS INC — $299K (0.2%)